S
VIR icon

SignatureFD’s Vir Biotechnology VIR Stock Holding History

SignatureFD’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.66K Hold
948
– – ﹤0.01% 2653
2026
Q1 		$8.49K Buy
948
+250
+36% +$1.99K ﹤0.01% 2574
2025
Q4 		$4.21K Sell
698
-82
-11% -$488 ﹤0.01% 2752
2025
Q3 		$4.45K Buy
780
+206
+36% +$1.05K ﹤0.01% 2722
2025
Q2 		$2.89K Buy
+574
New +$3.08K ﹤0.01% 2769
2025
Q1 		– Sell
-179
Closed -$1.31K – 3461
2024
Q4 		$1.31K Sell
179
-406
-69% -$3.2K ﹤0.01% 2980
2024
Q3 		$4.38K Sell
585
-2,539
-81% -$22.1K ﹤0.01% 2615
2024
Q2 		$27.8K Buy
3,124
+24
+0.8% +$230 ﹤0.01% 1806
2024
Q1 		$31.4K Sell
3,100
-227
-7% -$2.31K ﹤0.01% 1776
2023
Q4 		$33.5K Buy
3,327
+2,399
+259% +$21.9K ﹤0.01% 1664
2023
Q3 		$8.7K Buy
928
+869
+1,473% +$12.4K ﹤0.01% 2284
2023
Q2 		$1.45K Sell
59
-1,241
-95% -$31.2K ﹤0.01% 2887
2023
Q1 		$30.3K Buy
1,300
+1,208
+1,313% +$30.9K ﹤0.01% 1644
2022
Q4 		$2.33K Sell
92
-74
-45% -$1.81K ﹤0.01% 2756
2022
Q3 		$3K Buy
166
+8
+5% +$203 ﹤0.01% 2700
2022
Q2 		$4K Buy
158
+74
+88% +$1.73K ﹤0.01% 2559
2022
Q1 		$2K Sell
84
-91
-52% -$2.7K ﹤0.01% 2871
2021
Q4 		$7K Buy
175
+62
+55% +$2.43K ﹤0.01% 2300
2021
Q3 		$5K Buy
113
+26
+30% +$1.13K ﹤0.01% 2376
2021
Q2 		$4K Buy
+87
New +$3.96K ﹤0.01% 2388

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SignatureFD's VIR Position: Q2 2026 in Review

SignatureFD held its Vir Biotechnology (VIR) position steady in Q2 2026 at 948 shares worth $9.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

SignatureFD first reported a position in VIR in Q2 2021 and has held it in 20 quarters since. The position peaked at $33.5K in Q4 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • SignatureFD held 948 shares of Vir Biotechnology worth $9.66K as of Q2 2026.
  • SignatureFD left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2653 holding.
  • SignatureFD first reported a position in Vir Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • SignatureFD's Vir Biotechnology position peaked at $33.5K in Q4 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.